Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Reference52 articles.
1. 2017 GHR. Geneva: World Health Organization. Geneva; 2017. licence: CC BY-NC-SA 3.0 IGO.
2. Hernandez N, Mescia G, Pollio C, Robaina G, Quintana L, Bianchi C. Effectiveness of pegylated interferon alfa 2a and ribavirin for chronic hepatitis C in clinical practice. Acta Gastroenterol Latinoam. 2010;40:117–21.
3. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet (London, England). 2001;358:958–65. https://doi.org/10.1016/S0140-6736(01)06102-5 .
4. Hadziyannis SJ, Sette H, Morgan TR, Balan V, Diago M, Marcellin P, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med. 2004;140:346–55. https://doi.org/10.7326/0003-4819-140-5-200403020-00010 .
5. Manns MP, Wedemeyer H, Cornberg M. Treating viral hepatitis C: efficacy, side effects, and complications. Gut. 2006;55(9):1350. https://doi.org/10.1136/gut.2005.076646 .
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献